AU1566792A - New compounds for use in the treatment of cancer - Google Patents

New compounds for use in the treatment of cancer

Info

Publication number
AU1566792A
AU1566792A AU15667/92A AU1566792A AU1566792A AU 1566792 A AU1566792 A AU 1566792A AU 15667/92 A AU15667/92 A AU 15667/92A AU 1566792 A AU1566792 A AU 1566792A AU 1566792 A AU1566792 A AU 1566792A
Authority
AU
Australia
Prior art keywords
compound
electron
formula
hydroxymethyl
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15667/92A
Other languages
English (en)
Inventor
Michael Jarman
Ian Robert Judson
Derry Edward Vincent Wilman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research
Original Assignee
Institute of Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research filed Critical Institute of Cancer Research
Publication of AU1566792A publication Critical patent/AU1566792A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/70—Other substituted melamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU15667/92A 1991-03-22 1992-03-23 New compounds for use in the treatment of cancer Abandoned AU1566792A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919106170A GB9106170D0 (en) 1991-03-22 1991-03-22 New compounds for use in the treatment of cancer
GB9106170 1991-03-22

Publications (1)

Publication Number Publication Date
AU1566792A true AU1566792A (en) 1992-10-21

Family

ID=10692068

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15667/92A Abandoned AU1566792A (en) 1991-03-22 1992-03-23 New compounds for use in the treatment of cancer

Country Status (11)

Country Link
EP (1) EP0505220A1 (fr)
JP (1) JPH06511229A (fr)
AU (1) AU1566792A (fr)
CA (1) CA2106868A1 (fr)
GB (1) GB9106170D0 (fr)
IE (1) IE920889A1 (fr)
IL (1) IL101317A0 (fr)
MX (1) MX9201258A (fr)
TW (1) TW202437B (fr)
WO (1) WO1992016513A1 (fr)
ZA (1) ZA922073B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU676677B2 (en) * 1992-03-27 1997-03-20 Cancer Research Campaign Technology Limited Melamine derivatives for use in the treatment of cancer

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219776D0 (en) * 1992-09-18 1992-10-28 Inst Of Cancer The Research New compounds for use in the treatment of cancer
US6335339B1 (en) 1998-01-13 2002-01-01 Scriptgen Pharmaceuticals, Inc. Triazine antiviral compounds
WO1999036410A1 (fr) * 1998-01-13 1999-07-22 Scriptgen Pharmaceuticals, Inc. Composes de triazine antiviraux
WO2009157628A1 (fr) * 2008-06-23 2009-12-30 Industry-Academic Cooperation Foundation, Yonsei University Composition pharmaceutique pour le traitement ou la prévention d’un cancer comprenant un composé de triazine comme ingrédient actif
CN101684115B (zh) * 2008-09-26 2011-12-21 上海医药工业研究院 4-(5-((2-(4-吗啉基-6-苯氨基-1,3,5-三嗪-2-基)亚肼基)甲基)呋喃-2-基)苯甲酸、其制备方法及用途
CN104918923A (zh) * 2012-11-15 2015-09-16 加林制药公司 新型口服生物可利用的呼吸控制调节化合物及其使用方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU676677B2 (en) * 1992-03-27 1997-03-20 Cancer Research Campaign Technology Limited Melamine derivatives for use in the treatment of cancer

Also Published As

Publication number Publication date
GB9106170D0 (en) 1991-05-08
TW202437B (fr) 1993-03-21
MX9201258A (es) 1992-10-01
CA2106868A1 (fr) 1992-09-23
ZA922073B (en) 1992-11-25
JPH06511229A (ja) 1994-12-15
IE920889A1 (en) 1992-09-23
WO1992016513A1 (fr) 1992-10-01
EP0505220A1 (fr) 1992-09-23
IL101317A0 (en) 1992-11-15

Similar Documents

Publication Publication Date Title
AU713320B2 (en) Improved antiviral compounds
US4658058A (en) 11-O-methylspergualin
EP1471920B1 (fr) Procede de preparation de derives de phosphonooxymethyle d'alcool et de phenol
PL183885B1 (pl) Nowy związek, pochodna chloropirymidyny, sposób wytwarzania pochodnej chloropuryny, sposób wytwarzania pochodnej chloropirymidyny, sposób wytwarzania N-(2-amino-4,6-dichloro-5-pirymidynylo) formamidu, sposób wytwarzania 2,5-diamino-4,6-dichloropirymidyny, sposób wytwarzania 2,6-diaminopuryn i sposób wytwarzania (1S,4R)-4-[2-amino-6-(cyklopropyloamino)-9H-puryn-9-ylo]-2-cyklopenteno-1-metanolu
EA005561B1 (ru) Способ получения промежуточных соединений, применимых для получения противораковых соединений
US6559149B1 (en) Methotrexate derivatives
CA3035989A1 (fr) Compose aminomercaptan, son procede de preparation et son utilisation dans la protection contre le rayonnement
US5534625A (en) Melamine derivatives for use in the treatment of cancer
NZ243959A (en) Substituted pyrazine derivatives and pharmaceutical compositions thereof
AU1566792A (en) New compounds for use in the treatment of cancer
EP0537575A1 (fr) Bromhydrate d'un dérivé de DC-89 ayant une activité antitumorale
Jarman et al. Synthesis and cytotoxicity of potential tumor-inhibitory analogs of trimelamol (2, 4, 6-tris [(hydroxymethyl) methylamino]-1, 3, 5-triazine) having electron-withdrawing groups in place of methyl
CN111925318B (zh) 一个烟醇醚衍生物的马来酸盐及其晶型和应用
CA1226295A (fr) Complexes du platine de type acide glycolique
WO1993019075A1 (fr) Derives acides phosphoniques antiviraux d'analogues de purine
US20210323959A1 (en) Methods for purifying isavuconazonium sulfate
EP0654473B1 (fr) Dérivés de cyclopropane et agents antiviraux les contenant
FI57589B (fi) Foerfarande foer framstaellning av blodtrycket saenkande 6-substituerade 3-karbetoksihydrazinopyridaziner
DE3889993T2 (de) 2'-Deoxy-5-fluorouridin-Derivate.
US3049542A (en) Diazomethyltriazine derivatives
WO2017168442A1 (fr) Nouveaux sels stables de pémétrexed
WO1994006781A1 (fr) Nouveaux composes de traitement du cancer
EP0177728B1 (fr) Dérivés d'arphaménine, procédé pour leur préparation et leur utilisation comme médicament
Ainley et al. THE TRYPANOCIDAL ACTIVITY OF SOME PYRIMIDYL‐AMINOPHENYLARSONIC COMPOUNDS
KR810001525B1 (ko) 펩타이드 유도체의 제조방법